Opaleye Management Inc. 13D and 13G filings for Cardiff Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 5:20 pm Purchase | 2020-12-31 | 13G | Cardiff Oncology, Inc. CRDF | Opaleye Management Inc. | 1,662,500 4.710% | 414,500 (+33.21%) | Filing |
| 2020-08-28 5:15 pm Purchase | 2020-08-19 | 13G | Cardiff Oncology, Inc. CRDF | Opaleye Management Inc. | 1,248,000 5.370% | 1,248,000 (New Position) | Filing |